Literature DB >> 22703875

Isolated elevation of aldolase in the serum of myositis patients: a potential biomarker of damaged early regenerating muscle cells.

Livia Casciola-Rosen1, John C Hall, Andrew L Mammen, Lisa Christopher-Stine, Antony Rosen.   

Abstract

OBJECTIVES: Elevated serum aldolase A levels occur in the absence of elevated creatine kinase M (CK) levels in a subset of myositis patients. This study was undertaken to investigate the cell biology of this unexplained clinical observation.
METHODS: Cultured human myoblasts were differentiated in vitro. RNA and protein lysates were prepared and used to determine aldolase and CK gene and protein expression by QPCR and immunoblotting. Cardiotoxin was used to induce muscle injury and repair in an experimental mouse model, and aldolase A and CK were immunoblotted in the muscle lysates. Immunohistochemical staining was performed on myositis patient muscle paraffin sections to assess aldolase A and CK staining in vivo.
RESULTS: Aldolase A mRNA and protein expression is highest in differentiating myoblasts, and remains robust throughout differentiation. In contrast, CK mRNA and protein levels are low in undifferentiated myoblasts and become strikingly upregulated as differentiation progresses. Aldolase A protein expression is high in regenerating muscle in the mouse model of injury/repair, while CK expression was low. Immunohistochemical staining of human myositis biopsies showed that muscle cells with the highest levels of aldolase and no CK staining have features of regeneration.
CONCLUSIONS: In undifferentiated muscle cells, and those early in the differentiation process, aldolase A is expressed in the absence of CK. Thereafter, both are expressed. We propose that isolated serum aldolase A elevation in myositis patients (i) reflects preferential immune-mediated damage of early regenerative cells, and (ii) is a biomarker of damaged early regenerating muscle cells.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22703875      PMCID: PMC3786178     

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  14 in total

Review 1.  Polymyositis and dermatomyositis (first of two parts).

Authors:  A Bohan; J B Peter
Journal:  N Engl J Med       Date:  1975-02-13       Impact factor: 91.245

Review 2.  Polymyositis and dermatomyositis (second of two parts).

Authors:  A Bohan; J B Peter
Journal:  N Engl J Med       Date:  1975-02-20       Impact factor: 91.245

3.  Dermatomyositis with normal creatine kinase and elevated aldolase levels.

Authors:  J D Carter; K S Kanik; F B Vasey; J Valeriano-Marcet
Journal:  J Rheumatol       Date:  2001-10       Impact factor: 4.666

4.  Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis.

Authors:  Shinji Sato; Michito Hirakata; Masataka Kuwana; Akira Suwa; Shinichi Inada; Tsuneyo Mimori; Takeji Nishikawa; Chester V Oddis; Yasuo Ikeda
Journal:  Arthritis Rheum       Date:  2005-05

5.  Expression of the dermatomyositis autoantigen Mi-2 in regenerating muscle.

Authors:  Andrew L Mammen; Livia A Casciola-Rosen; John C Hall; Lisa Christopher-Stine; Andrea M Corse; Antony Rosen
Journal:  Arthritis Rheum       Date:  2009-12

Review 6.  The enzymology of skeletal muscle disorders.

Authors:  J A Lott; P W Landesman
Journal:  Crit Rev Clin Lab Sci       Date:  1984       Impact factor: 6.250

7.  Embryonic myogenesis pathways in muscle regeneration.

Authors:  Po Zhao; Eric P Hoffman
Journal:  Dev Dyn       Date:  2004-02       Impact factor: 3.780

8.  High aldolase with normal creatine kinase in serum predicts a myopathy with perimysial pathology.

Authors:  K Nozaki; A Pestronk
Journal:  J Neurol Neurosurg Psychiatry       Date:  2009-02-23       Impact factor: 10.154

9.  Comparison of clinical features and drug therapies among European and Latin American patients with juvenile dermatomyositis.

Authors:  Dinara Guseinova; Alessandro Consolaro; Lucia Trail; Cristina Ferrari; Angela Pistorio; Nicolino Ruperto; Antonella Buoncompagni; Clarissa Pilkington; Susan Maillard; Sheila K Oliveira; Flavio Sztajnbok; Ruben Cuttica; Fabrizia Corona; Maria Martha Katsicas; Ricardo Russo; Virginia Ferriani; Ruben Burgos-Vargas; Eunice Solis-Vallejo; Marcia Bandeira; Vicente Baca; Claudia Saad-Magalhaes; Clovis A Silva; Roberto Barcellona; Luciana Breda; Rolando Cimaz; Romina Gallizzi; Rosaria Garozzo; Silvana Martino; Antonella Meini; Achille Stabile; Alberto Martini; Angelo Ravelli
Journal:  Clin Exp Rheumatol       Date:  2011-02-23       Impact factor: 4.473

10.  Enhanced autoantigen expression in regenerating muscle cells in idiopathic inflammatory myopathy.

Authors:  Livia Casciola-Rosen; Kanneboyina Nagaraju; Paul Plotz; Kondi Wang; Stuart Levine; Edward Gabrielson; Andrea Corse; Antony Rosen
Journal:  J Exp Med       Date:  2005-02-21       Impact factor: 14.307

View more
  8 in total

Review 1.  The Clinical and Histological Spectrum of Idiopathic Inflammatory Myopathies.

Authors:  Ilaria Cavazzana; Micaela Fredi; Carlo Selmi; Angela Tincani; Franco Franceschini
Journal:  Clin Rev Allergy Immunol       Date:  2017-02       Impact factor: 8.667

Review 2.  [Inflammatory myopathies].

Authors:  Britta Maurer
Journal:  Z Rheumatol       Date:  2017-02       Impact factor: 1.372

3.  Immune Checkpoint Inhibitor-Induced Myocarditis with Myositis/Myasthenia Gravis Overlap Syndrome: A Systematic Review of Cases.

Authors:  Ranjan Pathak; Anjan Katel; Erminia Massarelli; Victoria M Villaflor; Virginia Sun; Ravi Salgia
Journal:  Oncologist       Date:  2021-08-25

Review 4.  [Dermatomyositis and juvenile dermatomyositis].

Authors:  Frank Dressler; Britta Maurer
Journal:  Z Rheumatol       Date:  2022-04-29       Impact factor: 1.372

5.  Pyomyositis presenting as myonecrosis secondary to methicillin-resistant Staphylococcus aureus bacteremia in chronic lymphocytic leukemia.

Authors:  Shannon Coombs; Albert Bui; Haares S Mirzan; Kimberly Robelin; Hillary W Garner; Murli Krishna; Jennifer B Cowart
Journal:  Proc (Bayl Univ Med Cent)       Date:  2022-05-31

Review 6.  Role of MRI in diagnosis and management of idiopathic inflammatory myopathies.

Authors:  Britta Maurer; Ulrich A Walker
Journal:  Curr Rheumatol Rep       Date:  2015-11       Impact factor: 4.592

Review 7.  Exploring Dermatomyositis through an Interdisciplinary Lens: Pearls from Dermatology and Rheumatology.

Authors:  Bina Kassamali; Daniel R Mazori; Avery H LaChance; Lisa Christopher-Stine
Journal:  Int J Womens Dermatol       Date:  2021-09-24

8.  Assessment of Optimal Screening Tests for the Detection of an Inflammatory Myositis-associated Interstitial Lung Disease.

Authors:  Sonia Castillo; Brietta Forbes; John Chen; Mark J Hamblin
Journal:  Cureus       Date:  2020-04-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.